FNEL planning to enter pharma sector

October 06, 2025 (MLN): First National Equities Limited (PSX: FNEL) is planning to enter into Pakistan’s fast-growing pharmaceutical sector with an investment of up to Rs500 million, as part of a diversified expansion plan approved by its Board of Directors.

According to the company’s filing to the Pakistan Stock Exchange (PSX), the investment will be made through the establishment or acquisition of a pharmaceutical manufacturing facility or company, either independently or in collaboration with its subsidiaries and associated undertakings.

The move marked FNEL’s significant diversification into a high-potential industry, reflecting its intent to tap into new growth avenues beyond its core portfolio.

In addition, the Board approved the divestment of the company’s 20% equity stake, comprising 10,000 Class-B non-voting shares, in Kingbhai Digisol (Private) Limited for a total consideration of Rs280 million.

The transaction values Kingbhai Digisol at approximately Rs1.5 billion, based on an independent valuation.

FNEL is also planning to inject up to Rs400 million into its subsidiary FNE Developments (Private) Limited through equity, loans, or other instruments to accelerate growth in real estate and infrastructure ventures with strong recurring revenue potential.

All three decisions are subject to shareholders’ and regulatory approvals where applicable.

Copyright Mettis Link News